ArticleHaematologica2021

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.

Mary-Elizabeth M Percival et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.